144 related articles for article (PubMed ID: 17700567)
21. Melatonin promotes differentiation of 3T3-L1 fibroblasts.
González A; Alvarez-García V; Martínez-Campa C; Alonso-González C; Cos S
J Pineal Res; 2012 Jan; 52(1):12-20. PubMed ID: 21718362
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
[TBL] [Abstract][Full Text] [Related]
23. Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production.
Alvarez-García V; González A; Alonso-González C; Martínez-Campa C; Cos S
J Pineal Res; 2012 Apr; 52(3):282-90. PubMed ID: 22151118
[TBL] [Abstract][Full Text] [Related]
24. Local estrogen formation by nontumoral, cirrhotic, and malignant human liver tissues and cells.
Castagnetta LA; Agostara B; Montalto G; Polito L; Campisi I; Saetta A; Itoh T; Yu B; Chen S; Carruba G
Cancer Res; 2003 Aug; 63(16):5041-5. PubMed ID: 12941832
[TBL] [Abstract][Full Text] [Related]
25. Rosiglitazone and pioglitazone inhibit estrogen synthesis in human granulosa cells by interfering with androgen binding to aromatase.
Seto-Young D; Avtanski D; Parikh G; Suwandhi P; Strizhevsky M; Araki T; Rosenwaks Z; Poretsky L
Horm Metab Res; 2011 Apr; 43(4):250-6. PubMed ID: 21321839
[TBL] [Abstract][Full Text] [Related]
26. Oestrogen formation in breast: clinical and biological importance.
Dowsett M; Detre S; Rowlands M; Grimshaw R
J Endocrinol; 1996 Sep; 150 Suppl():S59-63. PubMed ID: 8943788
[TBL] [Abstract][Full Text] [Related]
27. Effects of androgens on aromatase activity and 11C-vorozole binding in granulosa cells in vitro.
Kirilovas D; Naessen T; Bergström M; Bonasera TA; Bergström-Pettermann E; Holte J; Carlström K; Simberg N; Långström B
Acta Obstet Gynecol Scand; 2003 Mar; 82(3):209-15. PubMed ID: 12694114
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells.
Shinoda J; McLaughlin KE; Bell HS; Swaroop GR; Yamaguchi S; Holmes MC; Whittle IR
Glia; 2003 Apr; 42(1):68-76. PubMed ID: 12594738
[TBL] [Abstract][Full Text] [Related]
29. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
[TBL] [Abstract][Full Text] [Related]
30. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
31. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
[TBL] [Abstract][Full Text] [Related]
32. The aryl hydrocarbon receptor agonist 3,3',4,4',5-pentachlorobiphenyl induces distinct patterns of gene expression between hepatoma and glioma cells: chromatin remodeling as a mechanism for selective effects.
Maier MS; Legare ME; Hanneman WH
Neurotoxicology; 2007 May; 28(3):594-612. PubMed ID: 17316808
[TBL] [Abstract][Full Text] [Related]
33. Melatonin as a selective estrogen enzyme modulator.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Curr Cancer Drug Targets; 2008 Dec; 8(8):691-702. PubMed ID: 19075592
[TBL] [Abstract][Full Text] [Related]
34. Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes.
Sahin A; Vercamer C; Kaminski A; Fuchs T; Florin A; Hahne JC; Mattot V; Pourtier-Manzanedo A; Pietsch T; Fafeur V; Wernert N
Int J Oncol; 2009 Feb; 34(2):377-89. PubMed ID: 19148472
[TBL] [Abstract][Full Text] [Related]
35. Involvement of protein kinase C in melatonin's oncostatic effect in C6 glioma cells.
Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez-Blanco J; Medina M; Rodriguez C
J Pineal Res; 2007 Oct; 43(3):239-44. PubMed ID: 17803520
[TBL] [Abstract][Full Text] [Related]
36. Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells.
Martínez-Campa C; González A; Mediavilla MD; Alonso-González C; Alvarez-García V; Sánchez-Barceló EJ; Cos S
Br J Cancer; 2009 Nov; 101(9):1613-9. PubMed ID: 19773750
[TBL] [Abstract][Full Text] [Related]
37. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
38. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
[TBL] [Abstract][Full Text] [Related]
39. CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells.
Gensert JM; Baranova OV; Weinstein DE; Ratan RR
Neurobiol Dis; 2007 Jun; 26(3):671-80. PubMed ID: 17481908
[TBL] [Abstract][Full Text] [Related]
40. Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin.
Martín V; Herrera F; Carrera-Gonzalez P; García-Santos G; Antolín I; Rodriguez-Blanco J; Rodriguez C
Cancer Res; 2006 Jan; 66(2):1081-8. PubMed ID: 16424044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
